These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9052581

  • 1. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW.
    Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of oral 17 beta-estradiol.
    Lobo RA, Cassidenti DL.
    J Reprod Med; 1992 Jan; 37(1):77-84. PubMed ID: 1548642
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol.
    Kuhnz W, Gansau C, Mahler M.
    Arzneimittelforschung; 1993 Sep; 43(9):966-73. PubMed ID: 8240460
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H, Koytchev R, Mayer O, Börner A, Mellinger U, Breitbarth H.
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 6. Rapid absorption of micronized estradiol-17 beta following sublingual administration.
    Casper RF, Yen SS.
    Obstet Gynecol; 1981 Jan; 57(1):62-4. PubMed ID: 7454177
    [Abstract] [Full Text] [Related]

  • 7. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE.
    Zentralbl Gynakol; 1995 Jan; 117(10):504-7. PubMed ID: 7491831
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE, Bolt HM, Zwirner M, Hochlehnert G, Göser R.
    Arzneimittelforschung; 1982 Jan; 32(7):787-91. PubMed ID: 6289846
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT, Ross B, Anderson C, Archer DF.
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [Abstract] [Full Text] [Related]

  • 11. Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets.
    Eugster-Hausmann M, Waitzinger J, Lehnick D.
    Climacteric; 2010 Jun; 13(3):219-27. PubMed ID: 20423242
    [Abstract] [Full Text] [Related]

  • 12. Estradiol, estrone, and gonadotropin levels after use of vaginal estradiol.
    Martin PL, Greaney MO, Burnier AM, Brooks PM, Yen SS, Quigley ME.
    Obstet Gynecol; 1984 Apr; 63(4):441-4. PubMed ID: 6422370
    [Abstract] [Full Text] [Related]

  • 13. Bioequivalence of a 17 beta-estradiol hydroxypropyl-beta-cyclodextrin complex in postmenopausal women.
    Hoon TJ, Dawood MY, Khan-Dawood FS, Ramos J, Batenhorst RL.
    J Clin Pharmacol; 1993 Nov; 33(11):1116-21. PubMed ID: 8300895
    [Abstract] [Full Text] [Related]

  • 14. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL, Gattermeir DJ, Petersen CA, Day WW, Schumacher RJ.
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [Abstract] [Full Text] [Related]

  • 15. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C.
    Menopause; 2009 Sep; 16(1):30-6. PubMed ID: 18820592
    [Abstract] [Full Text] [Related]

  • 16. Half-life of estradiol in postmenopausal women.
    Ginsburg ES, Gao X, Shea BF, Barbieri RL.
    Gynecol Obstet Invest; 1998 Sep; 45(1):45-8. PubMed ID: 9473164
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT, Tangpricha V, Weinberg J, Malabanan AO, Chimeh FN, Holick MF.
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [Abstract] [Full Text] [Related]

  • 18. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM, Greenblatt DJ, Shader RI.
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [Abstract] [Full Text] [Related]

  • 19. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
    Dorr MB, Nelson AL, Mayer PR, Ranganath RP, Norris PM, Helzner EC, Preston RA.
    Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
    [Abstract] [Full Text] [Related]

  • 20. [What happens in our patients' bodies to the steroid hormones we prescribe? Pt. 1. Estrogens].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1981 Oct; 9(10):623-9. PubMed ID: 12311060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.